Pharm D (Clinical Pharmacy) – (New Bylaw 2019) – First Year – Semester 1
| Course code | Course title | CrH | L | T | P | CH | Pre-requisites |
| PPC 101 | Pharmacy Orientation | 1 | 1 | 0 | 0 | 1 | – |
| PPC 102 | Medical Terminology | 1 | 1 | 0 | 0 | 1 | – |
| PCC 101 | Pharmaceutical Analytical Chemistry I | 3 | 2 | 1 | 2 | 5 | – |
| PCC 102 | Pharmaceutical Organic Chemistry I | 3 | 2 | 1 | 2 | 5 | – |
| PCC 103 | Mathematics | 1 | 1 | 1 | 0 | 2 | – |
| PCC 104 | Information Technology I | 2 | 1 | 0 | 2 | 3 | – |
| PGC 101 | Human Rights and Fighting Corruption | 1 | 1 | 0 | 0 | 1 | – |
| PLC 101 | Cell Biology | 2 | 2 | 1 | 0 | 3 | – |
| UGA 03 | Arabic Language Skills | 2 | 2 | 0 | 0 | 2 | – |
| UGE 01 | English (1) | 2 | 0 | 2 | 2 | 4 | – |
| Total Semester | 18 | 13 | 6 | 8 | 27 |
Pharm D (Clinical Pharmacy) – (New Bylaw 2019) – First Year – Semester 2
| Course code | Course title | CrH | L | T | P | CH | Pre-requisites |
| PPC 103 | Physical Pharmacy | 3 | 2 | 0 | 2 | 4 | – |
| PCC 105 | Pharmaceutical AnalyticaI Chemistry Il | 3 | 2 | 1 | 2 | 5 | PCC 101 |
| PCC 106 | Pharmaceutical Organic Chemistry II | 3 | 2 | 1 | 2 | 5 | PCC 102 |
| PGC 102 | Medicinal Plants | 3 | 2 | 1 | 2 | 5 | – |
| PLC 102 | Anatomy and Histology | 3 | 2 | 0 | 2 | 4 | – |
| PLC 103 | Psychology | 1 | 1 | 1 | 0 | 2 | – |
| UGE 02 | English (2) | 2 | 0 | 2 | 2 | 4 | UGE 01 |
| Total Semester | 18 | 11 | 6 | 12 | 29 |
Pharm D (Clinical Pharmacy) – (New Bylaw 2019) – Second Year – Semester 3
| Course code | Course title | CrH | L | T | P | CH | Pre-requisites |
| PPC 201 | Pharmaceutical Dosage Forms I | 3 | 2 | 0 | 2 | 4 | PPC 103 |
| PPC 203 | Communication Skills I | 1 | 1 | 1 | 0 | 2 | – |
| PCC 201 | Pharmaceutical Organic Chemistry III | 2 | 1 | 1 | 2 | 4 | PCC 106 |
| PCC 202 | Instrumental Analysis | 2 | 2 | 1 | 0 | 3 | PCC 105 |
| PGC 201 | Pharmacognosy I | 3 | 2 | 1 | 2 | 5 | PGC 102 |
| PMC 201 | General Microbiology and Immunology | 3 | 2 | 0 | 2 | 4 | PLC 101 |
| PLC 201 | Biochemistry I | 3 | 2 | 0 | 2 | 4 | PCC 102 |
| PLC 202 | Physiology and pathophysiology | 2 | 2 | 1 | 0 | 3 | PLC 101 |
| Total Semester | 19 | 14 | 5 | 10 | 29 |
Pharm D (Clinical Pharmacy) – (New Bylaw 2019) – Second Year – Semester 4
| Course code | Course title | CrH | L | T | P | CH | Pre-requisites |
| PPC 202 | Pharmaceutical Dosage Forms II | 3 | 2 | 0 | 2 | 4 | PPC 103 |
| PGC 202 | Pharmacognosy II | 3 | 2 | 1 | 2 | 5 | PGC 201 |
| PMC 202 | Parasitology and Virology | 2 | 1 | 0 | 2 | 3 | PMC 201 |
| PLC 203 | Basic Pharmacology | 3 | 2 | 0 | 2 | 4 | PLC 202 |
| PLC 204 | Pathology | 2 | 2 | 1 | 0 | 3 | PLC 102 |
| PLC 205 | Biochemistry II | 3 | 2 | 0 | 2 | 4 | PLC 201 |
| PNC 201 | Biostatistics | 1 | 1 | 1 | 0 | 2 | PCC 103 |
| Total Semester | 19 | 13 | 4 | 12 | 29 |
Pharm D (Clinical Pharmacy) – (New Bylaw 2019) – Third Year – Semester 5
| Course code | Course title | CrH | L | T | P | CH | Pre-requisites |
| PPC 301 | Pharmaceutical Dosage Forms III | 3 | 2 | 0 | 2 | 4 | PPC 103 |
| PGC 301 | Phytochemistry I | 3 | 2 | 1 | 2 | 5 | PGC 202 |
| PMC 301 | Pharmaceutical Microbiology and Antimicrobials | 3 | 2 | 0 | 2 | 4 | PMC 201 |
| PMC 303 | Advanced scientific language | 2 | 0 | 2 | 2 | 4 | UGE 02 |
| PLC 301 | Pharmacology I | 3 | 2 | 0 | 2 | 4 | PLC 203 |
| PNC 301 | Scientific Writing | 1 | 1 | 1 | 0 | 2 | – |
| PNC 302 | Pharmaceutical Legislation and Practice Ethics |
1 | 1 | 0 | 0 | 1 | – |
| PNC 303 | Community Pharmacy Practice | 3 | 2 | 0 | 2 | 4 | PLC 202 PPC 202 |
| Total Semester | 19 | 12 | 4 | 12 | 28 |
Pharm D (Clinical Pharmacy) – (New Bylaw 2019) – Third Year – Semester 6
| Course code | Course title | CrH | L | T | P | CH | Pre-requisites |
| PPC 302 | Pharmaceutical Technology | 3 | 2 | 0 | 2 | 4 | PPC 201 PPC 202 |
| PPC 303 | Biopharmaceutics and Pharmacokinetics | 3 | 2 | 0 | 2 | 4 | PPC 301 |
| PPC 304 | Communication Skills II | 1 | 1 | 1 | 0 | 2 | PPC 203 |
| PGC 302 | Phytochemistry II | 3 | 2 | 1 | 2 | 5 | PGC 301 |
| PMC 302 | Medical Microbiology | 3 | 2 | 0 | 2 | 4 | PMC 201 |
| PLC 302 | Pharmacology II | 3 | 2 | 0 | 2 | 4 | PLC 203 |
| PLC 303 | First Aid and Basic Life Support (BLS) | 1 | 1 | 1 | 0 | 2 | PLC 301 |
| PNC 304 | Drug Information | 2 | 1 | 0 | 2 | 3 | – |
| Total Semester | 19 | 13 | 3 | 12 | 28 |
Pharm D (Clinical Pharmacy) – (New Bylaw 2019) – Fourth Year – Semester 7
| Course code | Course title | CrH | L | T | P | CH | Pre-requisites |
| PPC 401 | Advanced Drug Delivery Systems | 2 | 2 | 0 | 0 | 2 | PPC 201 PPC 303 |
| PCC 401 | Medicinal Chemistry I | 3 | 2 | 1 | 2 | 5 | PCC 201 PLC 203 |
| PCC 402 | Analytical Quality Control of Pharmaceuticals | 2 | 1 | 1 | 2 | 4 | PCC 202 |
| PMC 401 | Public Health and Preventive Medicine | 2 | 2 | 1 | 0 | 3 | PMC 302 |
| PLC 401 | Pharmacology III | 2 | 2 | 1 | 0 | 3 | PLC 203 |
| PNC 401 | Hospital Pharmacy | 3 | 2 | 0 | 2 | 4 | PLC 302 PPC 201 |
| PNC 402 | Clinical Pharmacokinetics | 3 | 2 | 0 | 2 | 4 | PPC 303 |
| E 01 | Elective 1 | 2 | 1 | 2 | 0 | 3 | – |
| Total Semester | 19 | 14 | 6 | 8 | 28 |
Pharm D (Clinical Pharmacy) – (New Bylaw 2019) – Fourth Year – Semester 8
| Course code | Course title | CrH | L | T | P | CH | Pre-requisites |
| PCC 403 | Medicinal Chemistry II | 3 | 2 | 1 | 2 | 5 | PCC 201 PLC 203 |
| PCC 404 | Information Technology II | 2 | 1 | 0 | 2 | 3 | PCC 104 |
| PLC 402 | Clinical Biochemistry | 3 | 2 | 0 | 2 | 4 | PLC 205 |
| PNC 403 | Clinical Pharmacy Practice | 3 | 2 | 0 | 2 | 4 | PLC 302 PPC 303 |
| PNC 404 | Management of Oncological Diseases and Radiopharmacy | 3 | 2 | 0 | 2 | 4 | PLC 401 |
| PNC 405 | Management of Endocrine and Renal Disorders | 3 | 2 | 0 | 2 | 4 | PLC 401 |
| E 02 | Elective 2 | 2 | 1 | 2 | 0 | 3 | – |
| Total Semester | 19 | 13 | 5 | 10 | 28 |
Pharm D (Clinical Pharmacy) – (New Bylaw 2019) – Fifth Year – Semester 9
| Course code | Course title | CrH | L | T | P | CH | Pre-requisites |
| PGC 501 | Phytotherapy | 2 | 2 | 1 | 0 | 3 | PGC 302 |
| PMC 501 | Pharmaceutical Biotechnology | 2 | 2 | 1 | 0 | 3 | PMC 302 |
| PLC 501 | Toxicology and Forensic Chemistry | 3 | 2 | 0 | 2 | 4 | PLC 302 |
| PNC 501 | Clinical Research, Pharmacoepidemiology and Pharmacovigilance | 1 | 1 | 1 | 0 | 2 | PMC 401 PNC 403 |
| PNC 502 | Management of Neuropsychiatry diseases | 3 | 2 | 0 | 2 | 4 | PLC 401 |
| PNC 503 | Management of Dermatological, Reproductive and Musculoskeletal Diseases | 3 | 2 | 0 | 2 | 4 | PLC 401 |
| PNC 504 | Management of Pediatric Diseases | 2 | 2 | 1 | 0 | 3 | PLC 203 |
| E 03 | Elective 3 | 2 | 1 | 2 | 0 | 3 | – |
| Total Semester | 18 | 14 | 6 | 6 | 26 |
Pharm D (Clinical Pharmacy) – (New Bylaw 2019) – Fifth Year – Semester 10
| Course code | Course title | CrH | L | T | P | CH | Pre-requisites |
| PLC 502 | Clinical Nutrition | 2 | 2 | 1 | 0 | 3 | PLC 205 |
| PNC 505 | Management of Cardiovascular Diseases | 3 | 2 | 0 | 2 | 4 | PLC 301 |
| PNC 506 | Management of Gastrointestinal Diseases | 3 | 2 | 0 | 2 | 4 | PLC 302 |
| PNC 507 | Management of Respiratory Diseases | 2 | 2 | 1 | 0 | 3 | PLC 302 |
| PNC 508 | Marketing and Pharmacoeconomics | 2 | 1 | 2 | 0 | 3 | PNC 501 PNC 401 |
| PNC 509 | Management of Critical Care Patients | 2 | 1 | 0 | 2 | 3 | PLC 401 PNC 403 |
| PNC 510 | Entrepreneurship | 1 | 1 | 1 | 0 | 2 | – |
| E 04 | Elective 4 | 2 | 1 | 2 | 0 | 3 | – |
| Total Semester | 17 | 12 | 7 | 6 | 25 |
Clinical Pharmacy & Pharmacy Practice Department (PN)
| No. | Course Code | Title | CrH | L | T | P | CH | Pr |
| 1 | PNC E01 | Management of chronic illness | 2 | 1 | 2 | 0 | 3 | PLC 301 |
| PNC 403 |
Microbiology and Immunology Department(PM)
| No. | Course Code | Title | CrH | L | T | P | CH | Pr |
| 2 | PMC E02 | Clinical immmunology | 2 | 1 | 2 | 0 | 3 | PMC 201 |
| 3 | PMC E03 | Mycology | 2 | 1 | 2 | 0 | 3 | PMC 201 |
| 4 | PMC E04 | Advanced microbiological techniques | 2 | 1 | 2 | 0 | 3 | PMC 302 |
Pharmaceutical Chemistry Department (PC)
| No. | Course Code | Title | CrH | L | T | P | CH | Pr |
| 1 | PCC E01 | Chromatography and Separation Techniques | 2 | 1 | 2 | 0 | 3 | PCC 202 |
| 2 | PCC E02 | Drug Design | 2 | 1 | 2 | 0 | 3 | PCC 401 |
| 3 | PCC E03 | Analysis of food and flavours. | 2 | 1 | 2 | 0 | 3 | PCC 202 |
| 4 | PCC E04 | Forensic analysis | 2 | 1 | 2 | 0 | 3 | PCC 202 |
| 5 | PCC E05 | Overview Of spectroscopy | 2 | 1 | 2 | 0 | 3 | PCC 201 |
| PCC 202 |
Pharmaceutics and Pharmaceutical Technology Department (PP)
| No. | Course Code | Title | CrH | L | T | P | CH | Pr |
| 1 | PPC E01 | Cosmetics Preparations | 2 | 1 | 2 | 0 | 3 | PPC 201 |
| PPC 202 | ||||||||
| 2 | PPC E02 | Good Manufacturing Practices | 2 | 1 | 2 | 0 | 3 | PPC 302 |
| 3 | PPC E03 | Pharmaceutical Nanotechnology | 2 | 1 | 2 | 0 | 3 | PPC 302 |
| 4 | PPC E04 | Supply Chain Mangement | 2 | 1 | 2 | 0 | 3 | – |
Pharmacognosy and Natural products Department (PG)
| No. | Course Code | Title | CrH | L | T | P | CH | Pr |
| 1 | PGC E01 | Processing of medicinal plants | 2 | 1 | 2 | 0 | 3 | – |
| 2 | PGC E02 | Complementary and Alternative | 2 | 1 | 2 | 0 | 3 | – |
| Medicine |
Pharmacology and Therapeutics Department (PL)
| No. | Course Code | Title | CrH | L | T | P | CH | Pr |
| 1 | PLC E01 | Pharmacotherapeutics for Special | 2 | 1 | 2 | 0 | 3 | PLC 203 |
| Population | ||||||||
| 2 | PLC E02 | Geriatric Pharmacotherapy | 2 | 1 | 2 | 0 | 3 | PLC 302 |
| PLC 401 | ||||||||
| 3 | PLC E03 | Addiction and Drug Abuse | 2 | 1 | 2 | 0 | 3 | PLC 203 |
| PLC 401 | ||||||||
| 4 | PLC E04 | Molecular Therapeutics | 2 | 1 | 2 | 0 | 3 | PLC 402 |
| Old System | ||
| Study Plane : PUA | ||
| Grade | MinimumScore | MaximumScore |
| A | 90 | 100 |
| A- | 85 | 89.5 |
| B+ | 80 | 84.5 |
| B | 75 | 79.5 |
| B- | 70 | 74.5 |
| C+ | 65 | 69.5 |
| C | 60 | 64.5 |
| C- | 56 | 59.5 |
| D+ | 53 | 55.5 |
| D | 50 | 52.5 |
| Power Campus | ||
| Curriculum ( Pharm D ,PharmD (Clinical)) | ||
| Grade | MinimumScore | MaximumScore |
| A+ | 97 | 100 |
| A | 90 | 96.5 |
| A- | 85 | 89.5 |
| B+ | 80 | 84.5 |
| B | 75 | 79.5 |
| C+ | 70 | 74.5 |
| C | 65 | 69.5 |
| D | 60 | 64.5 |